How does the updated classification system of gliomas impact your recommendations for radiation?
Using the WHO CNS5 classification, for subtotallly resected G2 astrocytoma, IDH-wild type, what RT dose would you use?
Join Mednetto vote and see how they answered.
Minesh Mehta and @Dr. First Last, Miami Cancer Institute
In 2021, the World Health Organization (WHO) introduced significant new changes to the classification of tumors of the central nervous system (CNS) in their 5th edition (WHO CNS5) (Louis et al., PMID 34185076). This step was the first of many ...
Join for free or sign in to see the full answer
The issue of IDH wild type malignant glioma without TERT promoter mutations remains one of the vexing issues with the current classification. It is estimated that perhaps about 20% of GBMs lack genetic alterations in IDH (hence IDH wild-type) and also the TERT promoter (hence TERTp wild-type). An in...
Join for free or sign in to see the full answer
ASTRO guidelines just published https://www.practicalradonc.org/article/S1879-8500(22)00144-8/fulltext#relatedArticles.
Join for free or sign in to see the full answer